Pancreatic Cancer Research

ResearcherUniversity Health NetworkActive in the last 2 years

Rama Khokha

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6028-1524; OpenAlex author ID A5044186566. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
42
Papers, trials and grants by year

2020: 2 papers · 2021: 2 papers · 2022: 2 papers · 2023: 2 papers · 2024: none · 2025: 1 paper

Papers 9

  1. Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. Co-author DOI 10.1038/s41467-024-55330-7↗
  2. Hourglass, a rapid analysis framework for heterogeneous bioimaging data, identifies sex disparity in IL-6/STAT3-associated immune phenotypes in pancreatic canc… Last author DOI 10.1002/path.6199↗
  3. Systemic inflammatory prognostic scores in advanced pancreatic adenocarcinoma. Co-author DOI 10.1038/s41416-023-02214-0↗
  4. Correlation of transcriptional subtypes with a validated CT radiomics score in resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00330-022-09057-y↗
  5. Correction: GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-22-1272↗
  6. Spatially confined sub-tumor microenvironments in pancreatic cancer. Last author DOI 10.1016/j.cell.2021.09.022↗
  7. TIMP1 expression underlies sex disparity in liver metastasis and survival in pancreatic cancer. Co-author DOI 10.1084/jem.20210911↗
  8. A Four-Chemokine Signature Is Associated with a T-cell-Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-19-2803↗
  9. GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-19-3724↗

Closest collaborators

The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Barbara T. Grünwald · 9 shared papers, 2020–2025 · strength 1.08
  2. Sandra Elisabeth Fischer · 7 shared papers, 2020–2023 · strength 0.78
  3. Steve Gallinger · 7 shared papers, 2020–2023 · strength 0.78
  4. Grainne Mary O'Kane · 6 shared papers, 2020–2023 · strength 0.63
  5. Jennifer Jane Knox · 6 shared papers, 2020–2023 · strength 0.63
  6. Faiyaz Notta · 5 shared papers, 2020–2023 · strength 0.49
  7. Robert C. Grant · 4 shared papers, 2020–2023 · strength 0.46
  8. Kazeera Aliar · 3 shared papers, 2021–2025 · strength 0.44
  9. Yifan Wang · 4 shared papers, 2020–2023 · strength 0.39
  10. George Zogopoulos · 4 shared papers, 2020–2023 · strength 0.39
  11. Niklas Krebs · 2 shared papers, 2023–2025 · strength 0.34
  12. James Biagi · 3 shared papers, 2020–2023 · strength 0.32
  13. Argyris Papantonis · 1 shared paper, 2025 · strength 0.18
  14. Elisa Espinet Espinet · 1 shared paper, 2025 · strength 0.18
  15. Shiv K. Singh · 1 shared paper, 2025 · strength 0.18
  16. Uday Kishore · 1 shared paper, 2025 · strength 0.18
  17. Muhammad Umair Latif · 1 shared paper, 2025 · strength 0.18
  18. Andreas Trumpp · 1 shared paper, 2025 · strength 0.18
  19. Laura Urbach · 1 shared paper, 2025 · strength 0.18
  20. Lukas Klein · 1 shared paper, 2025 · strength 0.18
  21. Mengyu Tu · 1 shared paper, 2025 · strength 0.18
  22. Rebecca Diya Samuel · 1 shared paper, 2025 · strength 0.18
  23. Elisabeth Heßmann · 1 shared paper, 2025 · strength 0.18
  24. Volker Ellenrieder · 1 shared paper, 2025 · strength 0.18
  25. Joan Miguel Romero · 2 shared papers, 2020–2021 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.